Evans Emily E, Wang Xin-Qun, Moore Christopher C
Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, VA, USA.
Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
Int J STD AIDS. 2016 Apr;27(5):370-6. doi: 10.1177/0956462415584489. Epub 2015 Apr 29.
There are few data regarding outcomes from severe sepsis for HIV-infected patients living in rural or semi-rural settings. We aim to describe the characteristics and predictors of mortality in HIV-infected patients admitted with severe sepsis to the University of Virginia located in semi-rural Charlottesville, Virginia, USA. We queried the University of Virginia Clinical Data Repository for cases with ICD-9 codes that included: (1) infection, (2) acute organ dysfunction, and (3) HIV infection. We reviewed each case to confirm the presence of HIV infection and severe sepsis. We recorded socio-demographic, clinical, and laboratory data. We used a generalised linear mixed-effects model to assess pre-specified predictors of mortality. We identified 74 cases of severe sepsis in HIV-infected patients admitted to University of Virginia since 2001. The median (IQR) age was 44 (36-49), 32 (43%) were women, and 56 (76%) were from ethnic minorities. The median (IQR) CD4+ T-cell count was 81 (7-281) cells/µL. In-hospital mortality was 20%. When adjusted for severity of illness and respiratory failure, patients who lived >40 miles away from care or had a CD4+ T cell count <50 cells/µL had > four-fold increased risk of death compared to the rest of the study population (AOR = 4.18, 95% CI: 1.09-16.07, p = 0.037; AOR = 4.33, 95% CI: 1.15-16.29, p = 0.03). In HIV-infected patients from rural and semi-rural Virginia with severe sepsis, mortality was increased in those that lived far from University of Virginia or had a low CD4+ T cell counts. Our data suggest that rural HIV-infected patients may have limited access to care, which predisposes them to critical illness and a high associated mortality.
关于生活在农村或半农村地区的HIV感染患者严重脓毒症的预后数据很少。我们旨在描述入住美国弗吉尼亚州夏洛茨维尔半农村地区弗吉尼亚大学的严重脓毒症HIV感染患者的死亡率特征和预测因素。我们查询了弗吉尼亚大学临床数据存储库中具有以下ICD-9编码的病例:(1)感染,(2)急性器官功能障碍,以及(3)HIV感染。我们复查了每个病例以确认HIV感染和严重脓毒症的存在。我们记录了社会人口统计学、临床和实验室数据。我们使用广义线性混合效应模型来评估预先指定的死亡率预测因素。自2001年以来,我们确定了74例入住弗吉尼亚大学的严重脓毒症HIV感染患者。年龄中位数(四分位间距)为44岁(36-49岁),32例(43%)为女性,56例(76%)为少数族裔。CD4+T细胞计数中位数(四分位间距)为81(7-281)个/微升。住院死亡率为20%。在对疾病严重程度和呼吸衰竭进行调整后,与研究人群的其他患者相比,居住在距离医疗机构40英里以外或CD4+T细胞计数<50个/微升的患者死亡风险增加了四倍多(调整后比值比=4.18,95%置信区间:1.09-16.07,p=0.037;调整后比值比=4.33,95%置信区间:1.15-16.29,p=0.03)。在弗吉尼亚州农村和半农村地区患有严重脓毒症的HIV感染患者中,居住在远离弗吉尼亚大学或CD4+T细胞计数低的患者死亡率增加。我们的数据表明,农村HIV感染患者获得医疗服务的机会可能有限,这使他们易患危重病并伴有高死亡率。